Leigh Pate passes, which is not only an unsurmountable loss for the ILC patient advocacy community, but for ILC research. Her contributions to lobular breast cancer have affected the lives of thousands of patients and their families, and this number will only continue to grow. She left a donation to BCRF which started a project aimed at generation of ILC patient-derived organoids (PDOs). This is a collaboration between UPMC Hillman Cancer Center, Memorial Sloan Kettering Cancer Center and the Institute for Precision Medicine, which Dr. Adrian Lee directs. Dr. Lee has made the generation of patient-derived breast cancer organoids, spearheaded by Dr. Daniel Brown, a priority of IPM. Dr. Jagmohan Hooda in the Lee/Oesterreich lab leads the characterization of ILC PDOs and the collaboration effort with MSKCC.
BCRF Legacy Project – An ILC Living Biobank
